Showing items 1391-1415 of 2549 (102 Page(s) Totally)
<< < 51 52 53 54 55 56 57 58 59 60 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-04-21T03:52:20Z |
Low-Threshold Lasing from 2D Homologous Organic-Inorganic Hybrid Ruddlesden-Popper Perovskite Single Crystals
|
Chen, C. W.; Raghavan, C. M.; Chen, T. P.; Li, S. S.; Chen, W. L.; Lo, C. Y.; Liao, Y. M.; Haider, G.; Lin, C. C.; Chen, C. C.; Sankar, R.; Chang, Y. M.; Chou, F. C. |
| 臺大學術典藏 |
2020-04-16T02:35:55Z |
MicroRNA-regulated protein-protein interaction networks and their functions in breast cancer
|
Lee, C.-H.;Kuo, W.-H.;Lin, C.-C.;Oyang, Y.-J.;Huang, H.-C.;Juan, H.-F.; YEN-JEN OYANG; Juan, H.-F.; Huang, H.-C.; Lee, C.-H.; Kuo, W.-H.; Lin, C.-C.; Oyang, Y.-J. |
| 臺大學術典藏 |
2020-04-16T02:35:17Z |
Response to "a note on the mapping and quantification of the human brain corticospinal tract"
|
Lin, C.-C.;Shen, W.-C.;Chung, H.-W.; Lin, C.-C.; Shen, W.-C.; Chung, H.-W.; HSIAO-WEN CHUNG |
| 臺大學術典藏 |
2020-04-16T02:34:21Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Tsay, W.; Chen, C.-Y.; Yao, M.; Li, C.-C.; Huang, S.-Y.; Ko, B.-S.; Hsu, S.-C.; Lin, C.-T.; Wu, S.-J.; Lin, L.-I.; Liu, C.-W.; Tsai, C.-H.;Hou, H.-A.;Tang, J.-L.;Kuo, Y.-Y.;Chiu, Y.-C.;Lin, C.-C.;Liu, C.-Y.;Tseng, M.-H.;Lin, T.-Y.;Liu, M.-C.;Liu, C.-W.;Lin, L.-I.;Yao, M.;Li, C.-C.;Huang, S.-Y.;Ko, B.-S.;Hsu, S.-C.;Lin, C.-T.;Wu, S.-J.;Chen, C.-Y.;Tsay, W.;Chuang, E.Y.;Chou, W.-C.;Tien, H.-F.; Tsai, C.-H.; Hou, H.-A.; Tang, J.-L.; Kuo, Y.-Y.; Chiu, Y.-C.; Lin, C.-C.; Liu, C.-Y.; Tseng, M.-H.; Lin, T.-Y.; Liu, M.-C.; Chuang, E.Y.; Chou, W.-C.; Tien, H.-F.; ERIC YAO-YU CHUANG |
| 臺大學術典藏 |
2020-04-10T12:51:25Z |
Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial
|
Yang C.-H.; Cheng A.-L.; Lin C.-C.;Chiun Hsu;Hsu C.-H.;Hsu W.-L.;Cheng A.-L.;Yang C.-H.; Lin C.-C.; Chiun Hsu; Hsu C.-H.; Hsu W.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:24Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Yang C.-H.; Chiun Hsu; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Lin C.-C.; Lin C.-C.;Yeh K.-H.;Yang C.-H.;Chiun Hsu;Tsai Y.-C.;Hsu W.-L.;Cheng A.-L.;Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:51:23Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Yang C.-H.; Yang P.-C.; Cheng A.-L.; Lin C.-C.; Hsu C.-H.; Yu C.-J.; Chang Y.-C.; Chiun Hsu; Lin Z.-Z. |
| 臺大學術典藏 |
2020-04-10T12:51:22Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Huang T.-C.; Yang P.-C.; Yang C.-H.; Lin C.-C.; Chiun Hsu; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-04-10T12:16:13Z |
Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.
|
YU-YUN SHAO; Lin C.C.; Yang C.H. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.;Lin C.-C.;Lin C.-Y.;Hsieh M.-S.;Kuo H.-Y.;Lien M.-Y.;Yu-Yun Shao;Huang T.-C.;Hsu C.-H.; Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; YU-YUN SHAO; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020-03-31T03:59:46Z |
Relationship between genetic polymorphisms of alcohol and aldehyde dehydrogenases and esophageal squamous cell carcinoma risk in males
|
Wu C.-F.;Wu D.-C.;Hsu H.-K.;Kao E.-L.;Jang-Ming Lee;Lin C.-C.;Wu M.-T.; Wu C.-F.; Wu D.-C.; Hsu H.-K.; Kao E.-L.; JANG-MING LEE; Lin C.-C.; Wu M.-T. |
| 臺大學術典藏 |
2020-03-31T03:59:46Z |
Annular esophageal leiomyoma mimicking a foregut cyst on endoscopic ultrasound
|
Lin C.-C.; Liu K.-L.; JANG-MING LEE; Wang H.-P.; Yang J.-C.; Lin C.-C.;Yang J.-C.;Wang H.-P.;Jang-Ming Lee;Liu K.-L. |
| 臺大學術典藏 |
2020-03-31T03:59:41Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu F.-M.;Lin C.-C.;Jang-Ming Lee;Chang Y.-L.;Hsu C.-H.;Tsai Y.-C.;Lee Y.-C.;Cheng J.C.-H.; Hsu F.-M.; Lin C.-C.; JANG-MING LEE; Chang Y.-L.; Hsu C.-H.; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-31T03:59:39Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Cheng J.C.-H.; Tsai Y.-C.; Wu J.-K.; Lin C.-C.; Hsu C.-H.; JANG-MING LEE; Lee Y.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-31T03:59:26Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang C.-C.;Cheng J.C.-H.;Tsai C.-L.;Jang-Ming Lee;Huang P.-M.;Lin C.-C.;Hsu C.-H.;Hsieh M.-S.;Chang Y.-L.;Hsu F.-M.; Wang C.-C.; Cheng J.C.-H.; Tsai C.-L.; JANG-MING LEE; Huang P.-M.; Lin C.-C.; Hsu C.-H.; Hsieh M.-S.; Chang Y.-L.; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-31T03:59:24Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Yeh K.-H.; Cheng A.-L.; Wang H.-P.; Cheng J.C.-H.; Hsu F.-M.; JANG-MING LEE; Huang P.-M.; Chang C.-H.; Lin C.-C.; Hsieh M.-S.; Guo J.-C.; Huang T.-C. |
| 臺大學術典藏 |
2020-03-31T03:59:16Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Hsu C.-H.;Jang-Ming Lee; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; JANG-MING LEE |
| 臺大學術典藏 |
2020-03-31T03:59:16Z |
Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
|
Huang P.-M.;Hsu F.-M.;Lin C.-C.;Hsu C.-H.;Cheng J.C.-H.;Jang-Ming Lee; Huang P.-M.; Hsu F.-M.; Lin C.-C.; Hsu C.-H.; Cheng J.C.-H.; JANG-MING LEE |
| 臺大學術典藏 |
2020-03-31T03:59:14Z |
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
|
Lu S.-L.;Hsu F.-M.;Tsai C.-L.;Jang-Ming Lee;Huang P.-M.;Hsu C.-H.;Lin C.-C.;Chang Y.-L.;Hsieh M.-S.;Cheng J.C.-H.; Lu S.-L.; Hsu F.-M.; Tsai C.-L.; JANG-MING LEE; Huang P.-M.; Hsu C.-H.; Lin C.-C.; Chang Y.-L.; Hsieh M.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-31T03:59:14Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Tzen K.-Y.; Cheng A.-L.; Yeh K.-H.; Hsu F.-M.; Huang P.-M.; JANG-MING LEE; Wang H.-P.; Chia-Hsien Cheng J.; Wu Y.-C.; Lin C.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Jang-Ming Lee;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H. |
| 臺大學術典藏 |
2020-03-30T08:51:15Z |
Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery
|
Lin C.-C.; Cheng J.-C.-H.; Wang Y.-H.; Chuang T.-H.; JIN-SHING CHEN; Hsu H.-H.; Huang P.-M.; Kuo S.-W.; Lee Y.-C.; Hsu C.-H.; Wu M.-T.; Shun C.-T.; Yang P.-W.; Yang S.-Y.; Lee J.-M.; Lee J.-M.;Yang S.-Y.;Yang P.-W.;Shun C.-T.;Wu M.-T.;Hsu C.-H.;Lin C.-C.;Cheng J.-C.-H.;Wang Y.-H.;Chuang T.-H.;Jin-Shing Chen;Hsu H.-H.;Huang P.-M.;Kuo S.-W.;Lee Y.-C. |
| 臺大學術典藏 |
2020-03-30T08:50:53Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Shih J.-Y.; JIN-SHING CHEN; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Jin-Shing Chen;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J.; Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y. |
| 臺大學術典藏 |
2020-03-30T08:50:43Z |
Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study
|
Chih-Hsin Yang J.; Chang C.-H.; Chao Y.-T.; Chang Y.-L.; Hsieh M.-S.; JIN-SHING CHEN; Lee J.-M.; Hsu F.-M.; Lin C.-C.; Ma W.-L.; Ma W.-L.;Lin C.-C.;Hsu F.-M.;Lee J.-M.;Jin-Shing Chen;Hsieh M.-S.;Chang Y.-L.;Chao Y.-T.;Chang C.-H.;Chih-Hsin Yang J. |
| 臺大學術典藏 |
2020-03-30T08:50:43Z |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Yang J.C.-H.; Yu C.-J.; Lin C.-C.; Shih J.-Y.; JIN-SHING CHEN; Lin Z.-Z.; Chen K.-Y.; Liao W.-Y.; Ho C.-C.; Yao Z.-H.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Jin-Shing Chen;Lin Z.-Z.;Lin C.-C.;Yang J.C.-H.;Yu C.-J. |
| 臺大學術典藏 |
2020-03-27T02:03:56Z |
Gastrointestinal: Lymphangioleiomyomatosis with protein-losing enteropathy
|
Wang H.-P.; Lin M.-T.; Lin J.-T.; KAO-LANG LIU; Lee T.-C.; Lin C.-C.;Lee T.-C.;Kao-Lang Liu;Lin J.-T.;Lin M.-T.;Wang H.-P.; Lin C.-C. |
Showing items 1391-1415 of 2549 (102 Page(s) Totally)
<< < 51 52 53 54 55 56 57 58 59 60 > >>
View [10|25|50] records per page
